维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="Trojaneck B"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅰ clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma 显示文摘	Schmidt-Wolf IG Finke S Trojaneck B	1999	British Journal of Cancer1999，81，6：	1
2	Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3 + CD56 + immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene显示文摘	FINKE S TROJANECK B LEFTEROVA P	1998	Gene Ther1998，5，4：	1
3	Increase of proliferation rate and enhancement of antitumor eytotoxicity of expanded human CD3^+ CD56^+ immunologic effector ceils by receptor-mediated transfection with the interleukin-7 gene 显示文摘	Finke S Trojaneck B Lefterova P	1998	Gene Ther1998，5，2：	1
4	Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer,colorectal cancer and lymphoma显示文摘	SCHMIDT-WOLF I G FINKE S TROJANECK B	1999	Br J Cancer1999，81，2：	1
5	Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancel colorectal cancer and lymphoma显示文摘	Schmidt-Wolf IG Finke S Trojaneck B	1999	Br J Cancel1999，81，6：	1
6	Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, coloreetal cancer and lymphoma 显示文摘	Schmidt-Wolf IG Finke S Trojaneck B	1999	Br J Cancer1999，81，6：	1
7	Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3 + CD56 + immunologic effector cells by receptor-mediated transfection with the interleukin 7 gene显示文摘	Finke S Trojaneck B Lefterova P	1998	Gene Ther1998，5，1：	1
8	Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene显示文摘	Finke S Trojaneck B Lefterova P	1998	Gene Ther1998，5，：	1
9	Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer,colorectal cancer and lymphoma显示文摘	Schmidt-Wolf IG Finke S Trojaneck B	1999	Br J Cancer1999，81，：	1
10	Phase I clinicalstudy applying autologous immunological effector cells transfectedwith the interleukin-2 gene in patients with metastatic renal Cancer,colorectal Cancer and lymphoma显示文摘	Schmidt-Wolf IG Finke S Trojaneck B	1999	Br J Cancer1999，81，6：	1
11	Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures显示文摘	Trojaneck B Niemitz S Micka B		0，，02：	1
12	Phase clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal canccr,colorectal cancer and lym- phoma显示文摘	Schmidt-Wolf IG Finke S Trojaneck B	2010	Cancer2010，81，6：	1
13	Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+CD56+ immunologic effector cells by receptor-mediated transfection with the Interleukin-7 gene显示文摘	FINKE S TROJANECK B LEFTEROVA P	1998	Gene Ther1998，5，1：	1
14	Increase of proliferation rate and enhancement of antitumor cyto-toxicity of expanded human CD3-CD56% immuno-logic effector cells by receptor mediated transfection with the interleukin 7 gene显示文摘	Finke S Trojaneck B Lefterova P	1998	C-ene Tiler1998，5，1：	1
15	Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma显示文摘	SCHMIDT-WOLF I G FINKE S TROJANECK B	1999	Br J Cancer1999，81，6：	1
16	Comparison of non- viral transfection methods in melanoma cell primary cultures 显示文摘	Trojaneck B Niemitz S	2000	Cytokine2000，12，：	1
17	Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma 显示文摘	Schmidt-Wolf I G Finke S Trojaneck B	1999	Br J Cancer1999，81，6：	1
18	Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma 显示文摘	Schmidt-Wolf IG Finke S Trojaneck B Denkena A Lefterova P Schwella N	1999	Br J Cancer1999，81，6：	1
19	Increase of proliferation rate and enhancement of antitumor cytoxicity of expanded human CD3^+CD56^+ immunologic effector cells by receptor -mediated transfection with the interleukin-7 gene显示文摘	FINKE S TROJANECK B LEFIEROVA P	1998	Gene Ther1998，5，1：	1
20	Increase of prolife- ration rate and enhancement of antitumor eytotoxieity ofexpanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene显示文摘	Finke S Trojaneck B Lefterova P	1998	Gene Ther1998，5，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示